Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
scientific article published on 8 March 2017
Author/s
author: Ana Arance, Piotr Rutkowski, Luc Thomas, Claus Garbe, Georgina V. Long, James M Ford, Paolo Antonio Ascierto, Keith Flaherty, David Hogg, Caroline Dutriaux, Paola Queirolo, Gabriella Liszkay, Michele Del Vecchio, Ralf Gutzmer, Mario Mandala, Dirk Schadendorf, Reinhard Dummer
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.